ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2644

Carotid Intima-Media Thickness and Plaque in Mexican Mestizos with Systemic Lupus Erythematosus: A Case-Control Study

Iris J. Colunga-Pedraza1, Dionicio A. Galarza-Delgado1, Alberto Cardenas-de La Garza1, Ana L. Sanchez-Nuñez1, Samantha L. Segarra-Linares1, Rocío A. Carrillo-Palacios1, David Vega-Morales1, Fernando Góngora-Rivera2 and Mario Alberto Garza-Elizondo1, 1Rheumatology, Hospital Universitario UANL, Monterrey, Mexico, 2Neurology., Hospital Universitario UANL, Monterrey, Mexico

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: atherosclerosis and cardiovascular disease, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose

Systemic lupus erythematosus (SLE) patients are at risk of premature cardiovascular disease (CVD). The specific reason of this situation is still debatable. Subclinical atherosclerosis prevalence and characteristics in Mexican mestizo patients with SLE is unknown. The objective of this study is to evaluate the presence of carotid plaque (CP) and carotid intima-media thickness (CIMT) in Mexican mestizos with SLE and to compare them to a control group.

Methods

An observational, cross-sectional study in a Mexican mestizo population was realized. 69 SLE patients, age ranging from 18 to 53 years, and 69 age-sex-diabetes-hypertension matched controls were included. Their demographic profile, biochemical, anthropometric measurements, traditional risk factors for atherosclerosis and disease-related factors were recorded. Carotid evaluation was realized by B mode carotid Doppler ultrasonography. CP was defined as presence of focal thickening at least 50% greater than that of the surrounding wall or CIMT ≥ 1.2 cm. The CIMT was measured at 1 cm proximal to the start of the carotid bulb dilatation of the common carotid artery in the far wall. The maximum CIMT value was recorded.

Results

Demographic differences between groups included a higher prevalence of CVD familiar history in the SLE group (p≤0.001), higher diastolic and systolic blood pressure in the SLE group (p≤0.001), and higher weight in the control group (p=0.013). Only 2 subjects of each group had diagnosis of hypertension, and 1 subject of each group had diagnosis of diabetes at the time of the enrollment to the study.

The mean CIM value in SLE patients was 0.514 ± 0.098 mm while the control group had a mean of 0.518 ± 0.108 mm (p=0.830). CP was found in 11 patients with SLE and 4 in the control group (p=0.360). SLE patients with CP had lower levels of total cholesterol (p=0.021), low density lipoprotein cholesterol (p=0.030) and glucose (0.003) compared with the control group with CP.

Patients in the SLE group with steroid use for more than five years were more likely to have CP or increased CIMT (p=0.023). Use of synthetic DMARD was associated with lower probability of CP or increased CIMT (p=0.048). This association was not found with biological DMARD (p=0.422).

Conclusion

Our study has shown that despite high prevalence of traditional cardiovascular risk factors among Mexicans SLE patients, the CP/CIMT findings were not completely attributable to them. These findings agree with most previously published reports in other populations including Asians, Caucasians and African-Americans. The actual evidence suggests that SLE itself is an independent predictor of atherosclerosis. The systematic carotid evaluation could be an important surrogate biomarker of premature atherosclerosis in our patients, and we recommend their systematic use.


Disclosure:

I. J. Colunga-Pedraza,
None;

D. A. Galarza-Delgado,
None;

A. Cardenas-de La Garza,
None;

A. L. Sanchez-Nuñez,
None;

S. L. Segarra-Linares,
None;

R. A. Carrillo-Palacios,
None;

D. Vega-Morales,
None;

F. Góngora-Rivera,
None;

M. A. Garza-Elizondo,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/carotid-intima-media-thickness-and-plaque-in-mexican-mestizos-with-systemic-lupus-erythematosus-a-case-control-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology